Geron Receives FDA Clearance to Begin World’s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy. Geron to Study GRNOPC1 in Patients with Acute Spinal Cord Injury. – Geron Corporation (Nasdaq: GERN) announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company’s Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
America’s Best Hospitals Way Ahead of World Health Organization on Surgical Checklist Use. Top U.S. hospitals have prevented thousands of deaths and complications by having surgeons use surgical safety checklists. – Recent hoopla surrounding published research citing the patient safety benefits of surgery checklists would suggest medical experts have stumbled onto a startling new tactic to prevent medical error.
Hospitals demonstrate surgical safety checklist drops deaths and complications by more than a third. – Hospitals in eight cities around the globe have successfully demonstrated that the use of a simple surgical checklist, developed by WHO, during major operations can lower the incidence of surgery-related deaths and complications by one third.
Building work starts on the largest IVF facility in the NHS, UK with ?3.3m. – A ?3.3m plan to reorganise Reproductive Medicine services in Leeds, bringing them together for the first time in a single purpose-designed facility which will improve care for fertility patients, is getting underway.
MRSA pre-screening effective in reducing otolaryngic surgical infection rates, revealed by researchers in Otolaryngology ? Head and Neck Surgery. – Pre-operative screening of patients for methicillin-resistant staphylococcus aureus (MRSA) may be an effective way to reduce infection rates following otolaryngic surgeries, according to new research published in the January 2009 issue of Otolaryngology ? Head and Neck Surgery.
Researchers at the University Of Southern California, School Of Dentistry release results of clinical data that links oral bisphosphonates to increased jaw necrosis. – A new research study revealed that there an increased risk jaw necrosis from oral bisphosphonates like Fossamax type drugs used for osteoporosis.
Circumcision Reduces the Risk of HIV Infection in Heterosexual US Men – A new U.S. study has found that being circumcised significantly reduced the risk of HIV infection in heterosexual African American men known to have been exposed to the virus.
In a British study, 43 eleven-year-old children born at less than 14 weeks (premature) were found less sensitive to temperature — cool, cold, warm and hot. – Premature infants who need intensive care or surgery are less sensitive to thermal (hot and cold) sensations later in life, according to research conducted at UCL (University College London).
Aesthetic Medicine has seen a dramatic increase in the diversity of the patients treated over the past decade and this trend is expected to continue to grow stronger than ever, with applications that cater to all people. – The American Society for Aesthetic Plastic Surgery (ASAPS), the leading national organization of board-certified plastic surgeons who specialize in cosmetic surgery, offers its predictions for cosmetic surgery in 2009.
Cancer drug bortezomib ? used to treat multiple myeloma – effectively treats organ transplant rejections. – University of Cincinnati (UC) researchers have discovered a new therapy for transplant patients, targeting the antibody-producing plasma cells that can cause organ rejection.
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE(TM) — First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes. New Prescription Product Increases Length, Thickness and Darkness of Eyelashes. – Allergan, Inc. (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.
Breathing life into injured lungs: World-first technique will expand lung donor organ pool – For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient.
